Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.

Bessey, A. orcid.org/0000-0001-7677-0309, Chilcott, J.B., Leaviss, J. orcid.org/0000-0002-5632-6021 et al. (1 more author) (2018) Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme. Orphanet Journal of Rare Diseases, 13. 179.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Adrenoleukodystrophy; Cost-benefit analysis; Cost-effectiveness analysis; Decision trees; Economic analysis; Hematopoietic stem cell transplantation; Neonatal screening; Newborn screening
Dates:
  • Accepted: 24 September 2018
  • Published: 11 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 19 Oct 2018 15:35
Last Modified: 19 Oct 2018 15:35
Published Version: https://doi.org/10.1186/s13023-018-0921-4
Status: Published
Publisher: BMC
Refereed: Yes
Identification Number: https://doi.org/10.1186/s13023-018-0921-4
Related URLs:

Export

Statistics